Proven clinical impact
Superior Patient Outcomes
Associated with a 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring1.
Clinical Confidence
FDA-cleared AI algorithms2 provide accurate, actionable data, significantly reducing "noise" and alert fatigue.
Predictive Intelligence
Leverage AI to proactively identify high-risk patients, such as those predicted for Heart Failure hospitalization3.
Time Reclaimed
Spend less time sifting through irrelevant alerts and more time focusing on critical patient management4.
A unified AI platform
Implicity provides a universal, AI-driven platform that integrates all your CIED data into a single, comprehensive view. Our solution cuts through data volume to deliver only the clinically relevant, high-quality information needed for confident, timely diagnostic and treatment decisions.
“Implicity stands apart for three key reasons: their FDA clearance, their ability to deliver vast amounts of discrete data, and their sophisticated use of AI. It’s not just about the AI they use today, but how that foundation allows for even greater innovation down the line.”
Universal Platform:
Consolidate data from the 5 major device manufacturers into one interface for seamless clinical review.
Signal HF3:
FDA-cleared algorithm that forecasts the risk of Heart Failure hospitalization.
ILR ECG Analyzer5:
Uses AI to reduce false positives by up to 79% in ILR ECG recordings, while maintaining high sensitivity6.
AF Alert Management7:
Detect clinically relevant events, leading to an 85% decrease in unnecessary Atrial Fibrillation burden alerts8.
- 1Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
- 2*IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information. SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
- 3SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
- 4Implicity study conducted in 2023 based on data from 56 medical centers, to measure the increase in productivity of medical teams after two years of using the Implicity platform.
- 5IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information.
- 6Rosier, Arnaud, et al., A novel machine learning algorithm has the potential to reduce by 1/3 the quantity of ILR episodes needing review, European Heart Journal, Volume 42, Issue Supplement_1, October 2021.
- 7IM009 AF Alert Management is a CE marked class I medical device (MDD 93/42/EEC), see the instructions for use for more information. Covered under the conditions defined in Article L. 162-52 of the French Social Security Code.
- 8Lazarus, Arnaud, et al. « Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithm. » Cardiovascular Digital Health Journal 4.5 (2023): 149-154.